• Nicholas J Felicione, Liane M Schneller, Maciej L Goniewicz, Andrew J Hyland, K Michael Cummings, Maansi Bansal-Travers, Geoffrey T Fong, and Richard J O'Connor.
• Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Electronic address: nicholas.felicione@roswellpark.org.
• Am J Prev Med. 2022 Oct 1; 63 (4): 611-618.

IntroductionTobacco-free oral nicotine products are an emerging class of noncombustible nicotine products. Oral nicotine product sales have increased since 2016, although little research has investigated consumer awareness, use, or correlates of oral nicotine product use. The purpose of this analysis was to assess the prevalence and correlates of oral nicotine product awareness and use.MethodsThis paper is a cross-sectional analysis of 2,507 U.S. participants from Wave 3 (February-June 2020) of the International Tobacco Control Four Country Smoking and Vaping Survey, a population-based survey of current and former cigarette smokers and nicotine vaping product users in the U.S. Oral nicotine product awareness and use prevalence were compared with those of heated tobacco products. Analyses conducted in late 2021 assessed the correlates of oral nicotine product awareness and use such as demographic characteristics, tobacco use (cigarettes, nicotine vaping products, smokeless tobacco), and tobacco quit attempts.ResultsAlmost 1 in 5 respondents claimed to have heard of oral nicotine products, 3.0% reported ever use, and 0.9% were current users, all of which were lower than for heated tobacco products. Ever use of oral nicotine products was more common among younger adults (e.g., aged 18-24 years), males, and current users of smokeless tobacco. Oral nicotine product prevalence was higher among those who reported having made attempts to stop smoking or vaping.ConclusionsOral nicotine product use was low among current and former smokers and nicotine vaping product users. Oral nicotine product users were demographically similar to use among individuals who smoke/vape and also use smokeless tobacco. Future studies are needed to understand emerging oral nicotine products, particularly whether they are being used as product supplements (dual use), replacements (switching), or cessation aids (quitting).Copyright © 2022 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

15 keywords...

hide…